8-(2-(1-(difluoromethyl)-1H-pyrazol-4-ylamino)-5-methylpyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-1-one

ID: ALA5077096

PubChem CID: 162351826

Max Phase: Preclinical

Molecular Formula: C17H21F2N7O

Molecular Weight: 377.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(Nc2cnn(C(F)F)c2)nc1N1CCC2(CCNC2=O)CC1

Standard InChI:  InChI=1S/C17H21F2N7O/c1-11-8-21-16(23-12-9-22-26(10-12)15(18)19)24-13(11)25-6-3-17(4-7-25)2-5-20-14(17)27/h8-10,15H,2-7H2,1H3,(H,20,27)(H,21,23,24)

Standard InChI Key:  ROOUYRXCMOACDH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   11.5601   -3.3821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2659   -2.9694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0915   -2.1706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2779   -2.0896    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9496   -2.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8532   -6.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8520   -7.0805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5601   -7.4895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2698   -7.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2669   -6.2574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5583   -5.8521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9781   -7.4875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6852   -7.0778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5559   -5.0349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2665   -4.6288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2660   -3.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8506   -3.8144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8494   -4.6342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1512   -3.0127    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1454   -5.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4304   -7.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9763   -6.7956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5665   -6.0885    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7675   -6.2597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8977   -5.3414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7103   -5.2546    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.3667   -4.5820    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  9 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 18  1  0
 15 16  1  0
 16  1  1  0
  1 17  1  0
 17 18  1  0
  5 19  2  0
  6 20  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 13  2  0
 23 25  1  0
 25 26  1  0
 25 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5077096

    ---

Associated Targets(Human)

JAK1 Tclin JAK1/TYK2 (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin JAK3/JAK1 (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin JAK1/JAK2/TYK2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin JAK2/TYK2 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin JAK2/JAK1 (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2E1 Tchem Cytochrome P450 2E1 (2174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

H9c2 (3506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.40Molecular Weight (Monoisotopic): 377.1776AlogP: 2.23#Rotatable Bonds: 4
Polar Surface Area: 87.97Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.27CX Basic pKa: 4.36CX LogP: 2.31CX LogD: 2.31
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.85Np Likeness Score: -1.42

References

1. Yang T, Cui X, Tang M, Qi W, Zhu Z, Shi M, Yang L, Pei H, Zhang W, Xie L, Xu Y, Yang Z, Chen L..  (2022)  Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease.,  65  (4.0): [PMID:35113547] [10.1021/acs.jmedchem.1c01137]

Source